1. Home
  2. GXO vs BIO Comparison

GXO vs BIO Comparison

Compare GXO & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GXO Logistics Inc.

GXO

GXO Logistics Inc.

HOLD

Current Price

$61.00

Market Cap

6.6B

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$281.42

Market Cap

7.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GXO
BIO
Founded
2021
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
7.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GXO
BIO
Price
$61.00
$281.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
$67.91
$358.50
AVG Volume (30 Days)
1.5M
288.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$13,178,000,000.00
N/A
Revenue This Year
$6.72
$2.31
Revenue Next Year
$6.12
$3.10
P/E Ratio
$225.70
$9.72
Revenue Growth
12.55
N/A
52 Week Low
$32.57
$211.43
52 Week High
$66.85
$343.12

Technical Indicators

Market Signals
Indicator
GXO
BIO
Relative Strength Index (RSI) 48.96 45.91
Support Level $51.38 $266.71
Resistance Level $66.85 $290.01
Average True Range (ATR) 2.37 9.20
MACD -0.43 1.44
Stochastic Oscillator 26.15 61.55

Price Performance

Historical Comparison
GXO
BIO

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: